Mark your calendar for Thursday, April 20th from 08:30 to 09:30 EST (14:30-15:30 CEST, SAST) for a presentation by Dr. Anneke Hesseling, MBChB, MSc, PhD, on the TB-CHAMP Trial.
The TB-CHAMP Trial is a phase III cluster randomized, double blind, placebo-controlled, superiority multicenter trial that aims to evaluate the efficacy of levofloxacin versus placebo as preventative therapy against MDR-TB in child and adolescent household contacts. The TB-CHAMP Trial expects to begin enrolling patients this year.
To join the event as an attendee:
2. Click “Join Now”.
To join the audio conference only:
Call-in toll-free number (US/Canada): 1-877-668-4490
Call-in toll number (US/Canada): 1-408-792-6300
Global call-in numbers: https://hms.webex.com/hms/globalcallin.php?serviceType=EC&ED=538690837&tollFree=0
Toll-free dialing restrictions: https://www.webex.com/pdf/tollfree_restrictions.pdf
Access code: 710 922 884